Physician profile
Douglas E Stabile
NPI 1467420059
$956.68
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $71.45 · 2021: $189 · 2022: $96.67 · 2023: $256 · 2024: $71.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $166.78 | 2021-2024 | Prophecy, Augment Injectable, Valor |
| Melinta Therapeutics, LLC | $152.73 | 2019 | |
| Horizon Therapeutics Plc | $95.10 | 2019-2021 | |
| Integra Lifesciences Corporation | $71.29 | 2019-2023 | Tenoglide |
| Triad Life Sciences INC. | $57.41 | 2022 | |
| Smith+Nephew, INC. | $56.21 | 2019-2021 | |
| Convatec INC. | $50.44 | 2023 | |
| Medtronic, INC. | $47.52 | 2023 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $38.68 | 2019 | |
| Sebela Pharmaceuticals INC. | $37.36 | 2019-2022 | |
| Organogenesis INC. | $36.40 | 2023 | Puraply |
| Ermi LLC | $35.23 | 2021 | |
| Paratek Pharmaceuticals, INC. | $29.83 | 2021-2022 | |
| Pfizer INC. | $27.86 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.20 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $15.65 | 2023 | V.A.C. Veraflo, Promogran Prisma, V.A.C. Dermatac |
| Hikma Pharmaceuticals USA | $13.58 | 2019 | |
| Orthofix Medical, INC. | $6.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Stabile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.